title: Pleural tumors as sole primary manifestation of acute promyelocytic leukemia.
authors.forename: B U
authors.initials: BU
authors.lastname: Mueller
authors.forename: A U
authors.initials: AU
authors.lastname: Buerger
authors.forename: M
authors.initials: M
authors.lastname: Solenthaler
authors.forename: E M
authors.initials: EM
authors.lastname: Garamvoelgyi
authors.forename: E
authors.initials: E
authors.lastname: Oppliger-Leibundgut
authors.forename: M F
authors.initials: MF
authors.lastname: Fey
authors.forename: T
authors.initials: T
authors.lastname: Pabst
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D010997:Pleural Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D014057:Tomography, X-Ray Computed
chemical_list: D003561:Cytarabine; D003630:Daunorubicin